The University of Colorado-Denver was awarded an Indefinite Delivery Contract (IDC) under the Accelerating Change and Transformation in Organizations and Networks IV (ACTION IV) IDIQ contract, a multiple-award vehicle administered by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The $5M ceiling contract, awarded in June 2020, has a period of performance through May 2025.
Under this IDC, the University of Colorado-Denver provides core function activities and administrative reporting to support the development of investigational medications for alcohol use disorder through the National Institute on Alcohol Abuse and Alcoholism's Medications Development Clinical Investigations Network. The university also holds significant experience delivering educational, public health, and biomedical research services to various federal agencies through prime and subcontractor contracts and grants. Key focus areas include diabetes, cancer, cardiovascular diseases, neurological disorders, and alcohol/drug abuse.
Generated 6/21/24, 9:07 AM